{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:16:39Z","timestamp":1775124999659,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202651"],"award-info":[{"award-number":["82202651"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0804500\/2020YFA0804501"],"award-info":[{"award-number":["2020YFA0804500\/2020YFA0804501"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cca.2025.120352","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:29:33Z","timestamp":1746988173000},"page":"120352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Method comparison and re-calibration of three top-used immunoassays and one LC-MS\/MS assay for four core cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: an explorative study for harmonization"],"prefix":"10.1016","volume":"575","author":[{"given":"Yutong","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenhui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-8144","authenticated-orcid":false,"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2025.120352_b0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jalz.2016.09.009","article-title":"Recommendations for cerebrospinal fluid Alzheimer\u2019s disease biomarkers in the diagnostic evaluation of mild cognitive impairment","volume":"13","author":"Herukka","year":"2017","journal-title":"Alzheimers. Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120352_b0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","article-title":"Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Leit\u00e3o","year":"2019","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.cca.2025.120352_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clinbiochem.2019.05.006","article-title":"Method comparison study of the Elecsys\u00ae \u03b2-Amyloid (1-42) CSF assay versus comparator assays and LC-MS\/MS","volume":"72","author":"Shaw","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120352_b0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clinbiochem.2022.11.013","article-title":"How far is the goal of applying \u03b2-amyloid in cerebrospinal fluid for clinical diagnosis of Alzheimer\u2019s disease with standardization of measurements?","volume":"112","author":"Zou","year":"2023","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.cca.2025.120352_b0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1373\/clinchem.2009.139477","article-title":"Liquid chromatography-isotope dilution-mass spectrometry as a new basis for the reference measurement procedure for hemoglobin A1c determination","volume":"56","author":"Kaiser","year":"2010","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.cca.2025.120352_b0030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1373\/clinchem.2013.220392","article-title":"Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-\u03b2 in cerebrospinal fluid","volume":"60","author":"Leinenbach","year":"2014","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.cca.2025.120352_b0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1515\/cclm-2022-1250","article-title":"Development of a candidate reference measurement procedure by ID-LC-MS\/MS for total tau protein measurement in cerebrospinal fluid (CSF)","volume":"61","author":"Giangrande","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2025.120352_b0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1373\/clinchem.2017.281055","article-title":"Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-\u03b2 1-42 Analysis Results","volume":"64","author":"Tijms","year":"2018","journal-title":"Clin. Chem."},{"issue":"18","key":"10.1016\/j.cca.2025.120352_b0045","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1007\/s00216-023-04631-9","article-title":"Advances in sample preparation and HPLC-MS\/MS methods for determining amyloid-\u03b2 peptide in biological samples: a review","volume":"415","author":"de Souza","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.cca.2025.120352_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2025.120352_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1119070","article-title":"Association of APOE \u03b54\/\u03b54 with fluid biomarkers in patients from the PUMCH dementia cohort","volume":"15","author":"Shang","year":"2023","journal-title":"Front. Aging. Neurosci."},{"issue":"9","key":"10.1016\/j.cca.2025.120352_b0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/alz.12316","article-title":"The Alzheimer\u2019s Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid \u03b2 and tau","volume":"17","author":"Hansson","year":"2021","journal-title":"Alzheimers. Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120352_b0065","article-title":"Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status","volume":"13","author":"Willemse","year":"2021","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)"},{"issue":"2","key":"10.1016\/j.cca.2025.120352_b0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ab.2011.08.010","article-title":"Quantitation of amyloid beta peptides A\u03b2(1-38), A\u03b2(1-40), and A\u03b2(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"419","author":"Lame","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cca.2025.120352_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464531","article-title":"Automated magnetic-bead-assisted sequential extraction technology for simultaneous detection of A\u03b21-42 and A\u03b21-40 in cerebrospinal fluid: An advance toward fully automated liquid chromatography-tandem mass spectrometry method","volume":"1713","author":"Zou","year":"2024","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.cca.2025.120352_b0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fnins.2015.00302","article-title":"Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry","volume":"9","author":"Bros","year":"2015","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.cca.2025.120352_b0085","article-title":"Pre-analytical protocol for measuring Alzheimer\u2019s disease biomarkers in fresh CSF","volume":"12","author":"Hansson","year":"2020","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)."},{"issue":"9","key":"10.1016\/j.cca.2025.120352_b0090","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00415-019-09418-6","article-title":"Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid A\u03b2(42) and T-Tau assays for Alzheimer\u2019s disease diagnosis","volume":"266","author":"Bayart","year":"2019","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120352_b0095","article-title":"Concordance of CSF measures of Alzheimer\u2019s pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays","volume":"13","author":"Keshavan","year":"2021","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)"},{"issue":"4","key":"10.1016\/j.cca.2025.120352_b0100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3233\/JAD-2012-121471","article-title":"A selected reaction monitoring (SRM)-based method for absolute quantification of A\u03b238, A\u03b240, and A\u03b242 in cerebrospinal fluid of Alzheimer\u2019s disease patients and healthy controls","volume":"33","author":"Pannee","year":"2013","journal-title":"J. Alzheimers. Dis."},{"issue":"12","key":"10.1016\/j.cca.2025.120352_b0105","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/jamaneurol.2017.2814","article-title":"Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment","volume":"74","author":"Janelidze","year":"2017","journal-title":"JAMA Neurol."},{"issue":"Pt 9","key":"10.1016\/j.cca.2025.120352_b0110","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/brain\/aww160","article-title":"Pittsburgh compound B imaging and cerebrospinal fluid amyloid-\u03b2 in a multicentre European memory clinic study","volume":"139","author":"Leuzy","year":"2016","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.cca.2025.120352_b0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2021-0651","article-title":"Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid","volume":"60","author":"Gobom","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.cca.2025.120352_b0120","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1-42) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers. Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120352_b0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13195-020-00767-3","article-title":"Alzheimer\u2019s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans\u00a0: CSF AD biomarkers measured by Lumipulse in Koreans","volume":"13","author":"Moon","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2025.120352_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.604119","article-title":"Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest","volume":"13","author":"Dakterzada","year":"2021","journal-title":"Front. Aging. Neurosci."},{"key":"10.1016\/j.cca.2025.120352_b0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2019.02.033","article-title":"Comparative evaluation of two immunoassays for cerebrospinal fluid \u03b2-Amyloid(1-42) measurement","volume":"493","author":"Zecca","year":"2019","journal-title":"Clin. Chim. Acta."},{"issue":"13","key":"10.1016\/j.cca.2025.120352_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136891","article-title":"Establishing In-House Cutoffs of CSF Alzheimer\u2019s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort","volume":"23","author":"Orellana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120352_b0145","first-page":"563","article-title":"Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer\u2019s disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project","volume":"10","author":"Willemse","year":"2018","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)"},{"issue":"9","key":"10.1016\/j.cca.2025.120352_b0150","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1515\/cclm-2023-0191","article-title":"Measurement of amyloid-\u03b2 1-42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTEST","volume":"61","author":"Dimopoulos","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.cca.2025.120352_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102667","article-title":"A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer\u2019s Disease","volume":"10","author":"Arcaro","year":"2022","journal-title":"Biomedicines."},{"issue":"1","key":"10.1016\/j.cca.2025.120352_b0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13195-020-00689-0","article-title":"Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?","volume":"12","author":"Bellomo","year":"2020","journal-title":"Alzheimers. Res. Ther."},{"issue":"2","key":"10.1016\/j.cca.2025.120352_b0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/acs.jproteome.5b01001","article-title":"Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity","volume":"15","author":"Barth\u00e9lemy","year":"2016","journal-title":"J. Proteome. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120352_b0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13024-022-00586-0","article-title":"Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer\u2019s disease continuum","volume":"17","author":"Gobom","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.cca.2025.120352_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076523","article-title":"Characterization of novel CSF Tau and ptau biomarkers for Alzheimer\u2019s disease","volume":"8","author":"Meredith","year":"2013","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.cca.2025.120352_b0180","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau Kinetics in Neurons and the Human Central Nervous System","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.cca.2025.120352_b0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-132489","article-title":"Qualification of a surrogate matrix-based absolute quantification method for amyloid-\u03b242 in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry","volume":"41","author":"Korecka","year":"2014","journal-title":"J. Alzheimers. Dis."},{"issue":"4","key":"10.1016\/j.cca.2025.120352_b0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/clinchem\/hvaa012","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO\/2 Participants by an LC-MS\/MS Reference Method","volume":"66","author":"Korecka","year":"2020","journal-title":"Clin. Chem."},{"issue":"12","key":"10.1016\/j.cca.2025.120352_b0195","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1515\/cclm-2018-0147","article-title":"Commutability of the certified reference materials for the standardization of \u03b2-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and \u03b2-amyloid 1-40 measurements","volume":"56","author":"Andreasson","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.cca.2025.120352_b0200","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1515\/cclm-2015-0733","article-title":"Assessing the commutability of reference material formats for the harmonization of amyloid-\u03b2 measurements","volume":"54","author":"Bjerke","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"19","key":"10.1016\/j.cca.2025.120352_b0205","doi-asserted-by":"crossref","first-page":"13229","DOI":"10.1021\/acs.analchem.0c02381","volume":"92","author":"Feng","year":"2020","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.cca.2025.120352_b0210","article-title":"Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer's disease","volume":"15","author":"Giangrande","year":"2023","journal-title":"Alzheimers Dement (Amst)."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:07:02Z","timestamp":1762114022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125002311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"alternative-id":["S0009898125002311"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120352","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Method comparison and re-calibration of three top-used immunoassays and one LC-MS\/MS assay for four core cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: an explorative study for harmonization","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120352"}}